These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7700008)

  • 41. Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity.
    Alonso-Galicia M; Brands MW; Zappe DH; Hall JE
    Hypertension; 1996 Dec; 28(6):1047-54. PubMed ID: 8952595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glomerular losartan (DuP 753)-sensitive angiotensin II receptor density is increased in young spontaneously hypertensive rats.
    Haws RM; Shaul PW; Arant BS; Atiyeh BA; Seikaly MG
    Pediatr Res; 1994 Jun; 35(6):671-6. PubMed ID: 7936816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional evidence that the angiotensin antagonist losartan crosses the blood-brain barrier in the rat.
    Li Z; Bains JS; Ferguson AV
    Brain Res Bull; 1993; 30(1-2):33-9. PubMed ID: 8420632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fos-related antigen immunoreactivity after acute and chronic angiotensin II-induced hypertension in the rabbit brain.
    Davern PJ; Head GA
    Hypertension; 2007 May; 49(5):1170-7. PubMed ID: 17339536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of c-fos expression in the lamina terminalis of conscious rats after intravenous or intracerebroventricular angiotensin.
    McKinley MJ; Badoer E; Vivas L; Oldfield BJ
    Brain Res Bull; 1995; 37(2):131-7. PubMed ID: 7606488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
    Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Angiotensin-II receptor blockers].
    Metelitsa VI
    Ter Arkh; 1996; 68(8):64-7. PubMed ID: 9019837
    [No Abstract]   [Full Text] [Related]  

  • 49. Renal actions of the angiotensin AT2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin system.
    Macari D; Whitebread S; Cumin F; De Gasparo M; Levens N
    Eur J Pharmacol; 1994 Jun; 259(1):27-36. PubMed ID: 7957590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renin-angiotensin system and minoxidil-induced cardiac hypertrophy in rats.
    Ruzicka M; Leenen FH
    Am J Physiol; 1993 Nov; 265(5 Pt 2):H1551-6. PubMed ID: 8238566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of angiotensin receptor subtypes in osmotically induced release of vasopressin.
    Hogarty DC; Tran DN; Phillips MI
    Brain Res; 1994 Feb; 637(1-2):126-32. PubMed ID: 8180789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypertrophic growth of cultured neonatal rat heart cells mediated by type 1 angiotensin II receptor.
    Miyata S; Haneda T
    Am J Physiol; 1994 Jun; 266(6 Pt 2):H2443-51. PubMed ID: 8024006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding of angiotensin antagonists to rat liver and brain membranes measured ex vivo.
    Marshall FH; Clark SA; Michel AD; Barnes JC
    Br J Pharmacol; 1993 Jul; 109(3):760-4. PubMed ID: 8358571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tonic neuronal inhibition by AII revealed by iontophoretic application of Losartan, a specific antagonist of AII type-1 receptors.
    Martial FP; Thornton SN; Lienard F; Mousseau MC; Nicolaidis S
    Brain Res Bull; 1994; 34(6):533-9. PubMed ID: 7922595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
    Gorbea-Oppliger VJ; Melaragno MG; Potter GS; Petit RL; Fink GD
    J Pharmacol Exp Ther; 1994 Nov; 271(2):804-10. PubMed ID: 7965799
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II.
    Gorbea-Oppliger VJ; Fink GD
    J Pharmacol Exp Ther; 1995 May; 273(2):611-6. PubMed ID: 7752062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oestrogen and weight loss decrease isoproterenol-induced Fos immunoreactivity and angiotensin type 1 mRNA in the subfornical organ of female rats.
    Krause EG; Curtis KS; Stincic TL; Markle JP; Contreras RJ
    J Physiol; 2006 May; 573(Pt 1):251-62. PubMed ID: 16543266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats.
    Zou LX; Imig JD; von Thun AM; Hymel A; Ono H; Navar LG
    Hypertension; 1996 Oct; 28(4):669-77. PubMed ID: 8843896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiotensin II receptor antagonists: the prototype losartan.
    Schaefer KL; Porter JA
    Ann Pharmacother; 1996 Jun; 30(6):625-36. PubMed ID: 8792950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.